Evidence map›Paper›PMID 33816079›Full record

ArticleBalkan journal of medical genetics : BJMG2020

Two Novel

P E Tokgun, M T Alay, S Atli Tekin, N Güler, O Tokgun, A Demiray, N Karagenc, T Durak, B Celik, H Akca

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

P E TokgunDepartment of Medical Genetics, Pamukkale University, Denizli, Turkey.
M T AlayDepartment of Medical Genetics, Cerrahpaşa University, Istanbul, Turkey.
S Atli TekinDepartment of Medical Genetics, Pamukkale University, Denizli, Turkey.
N GülerDepartment of Internal Medicine, Division of Hematology, Pamukkale University, Denizli, Turkey.
O TokgunDepartment of Medical Genetics, Pamukkale University, Denizli, Turkey.
A DemirayDepartment of Medical Genetics, Pamukkale University, Denizli, Turkey.
N KaragencDepartment of Medical Genetics, Pamukkale University, Denizli, Turkey.
T DurakDepartment of Medical Genetics, Pamukkale University, Denizli, Turkey.
B CelikDepartment of Internal Medicine, Division of Hematology, Pamukkale University, Denizli, Turkey.
H AkcaDepartment of Medical Genetics, Pamukkale University, Denizli, Turkey.
Pamukkale University · TRIstanbul University-Cerrahpaşa · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) was first categorized in 1976 by French, American and British researchers, and divided into eight subgroups (M0 to M7), depending on the cytochemical or histological changes in the leukemic cells. The gene mutations of

Indexed as

Acute myeloid leukemia (AML)CEBPA geneNovel mutationPeripheral bloodSanger sequencing

Identifiers

PMID33816079
PMCPMC8009566
OpenAlexW3144861405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.